8-K//Current report
PharmaCyte Biotech, Inc. 8-K
Accession 0001683168-25-007871
$PMCBCIK 0001157075operating
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 4:05 PM ET
Size
350.8 KB
Accession
0001683168-25-007871
Documents
- 8-Kpharmacyte_8k.htmPrimary
FORM 8-K
- EX-10.1pharmacyte_ex1001.htm
PHARMACYTE BIOTECH, INC. 2022 EQUITY INCENTIVE PLAN, AS AMENDED
- EX-101.SCHpmcb-20251030.xsd
XBRL SCHEMA FILE
- EX-101.LABpmcb-20251030_lab.xml
XBRL LABEL FILE
- EX-101.PREpmcb-20251030_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001683168-25-007871-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLpharmacyte_8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
PharmaCyte Biotech, Inc.
CIK 0001157075
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001157075
Filing Metadata
- Form type
- 8-K
- Filed
- Oct 30, 8:00 PM ET
- Accepted
- Oct 31, 4:05 PM ET
- Size
- 350.8 KB